Dr Arturo Vegas (Assistant Professor of Chemistry, Boston University Centre for Molecular Discovery, Boston, MA, US) explains the fundamentals of nanotechnology and how this can be applied to the treatment of type 1 and type 2 diabetes. He also discusses “smart” insulins, which are more glucose responsive. The use of these insulins would mean patients wouldn’t have to perform blood-sugar checks throughout the day. Dr Vegas hopes this would lead to improved long-term disease control. Finally, Dr Vegas briefly reviews the emergence of new therapies and technologies for the treatment of diabetes; he expects to see dramatic changes in the way we treat diabetes in the future.
1. What is nanotechnology? (0:13)
2. What are the latest advances in nanotechnology for the treatment of diabetes? (0:44)
3. How do you think the area of “Smart” (Gluco-Sensing) insulins will evolve over the next few years? (2:07)
4. What are your highlights from this year’s ADA meeting? (3:22)
Filmed at the American Diabetes Association (ADA) Annual Meeting, June 2018